Display options
Share it on

Clin Kidney J. 2015 Dec;8(6):789-95. doi: 10.1093/ckj/sfv096. Epub 2015 Oct 06.

A 4-month programme of in-centre nocturnal haemodialysis was associated with improvements in patient outcomes.

Clinical kidney journal

Matthew P M Graham-Brown, Darren R Churchward, Alice C Smith, Richard J Baines, James O Burton

Affiliations

  1. John Walls Renal Unit , Leicester General Hospital , Leicester , UK ; Department of Infection, Immunity and Inflammation , University of Leicester , Leicester , UK.
  2. John Walls Renal Unit , Leicester General Hospital , Leicester , UK ; Department of Infection, Immunity and Inflammation , University of Leicester , Leicester , UK ; Department of Cardiovascular Science , NIHR Leicester Cardiovascular Biomedical Research Unit , Leicester , UK.

PMID: 26613041 PMCID: PMC4655800 DOI: 10.1093/ckj/sfv096

Abstract

BACKGROUND: Extended periods of haemodialysis (HD) can improve patient outcomes. In-centre nocturnal haemodialysis (INHD) should be explored as a method of offering extended periods of HD to patients unsuitable for or unable to perform home therapy.

METHODS: Ten self-selecting, prevalent HD patients started an INHD programme to assess feasibility and patient satisfaction. Quality-of-life (QOL) measures were evaluated at enrolment and after 4 months of INHD using the EQ-5D, the Hospital Anxiety and Depression Scale (HADS) and the SF-12 questionnaires. Demographic, biochemical and haematological data and data on dialysis adequacy were collected before starting INHD and after 4 months.

RESULTS: Three of the 10 patients failed to complete the 2-week run-in period. Seven patients completed the 4-month programme, with mean dialysis time of 355 ± 43.92 min throughout the period. The EQ-5D visual analogue score improved from 48 ± 16.89 to 72 ± 13.2 (P = 0.003) and the HADS anxiety score decreased from 9 ± 5.83 to 3.57 ± 3.04 (P = 0.029). The urea reduction ratio improved from 71.57 ± 2.29% to 80.43 ± 3.101% (P < 0.001), with improvements in phosphate control, reducing to within the target range from 1.73 ± 0.6 to 1.2 ± 0.2 (P = 0.08). Ultrafiltration (UF) volumes increased during the study from 2000 ± 510 to 2606 ± 343 mL (P = 0.015); there was a significant reduction in mean UF rate adjusted for body weight from 6.47 ± 1.71 to 4.61 ± 1.59 mL/kg/h (P = 0.032). Sensitivity analyses confirmed the significance of these results.

CONCLUSIONS: This single-centre study showed a 4-month programme of extended hours INHD is safe and associated with improvements in QOL measures, decreased UF rates and measures of dialysis adequacy. These data have been used to expand our service and inform the design of future randomized controlled trials to examine medical endpoints.

Keywords: QOL; dialysis; in-centre; nocturnal; ultrafiltration rate

References

  1. Nephrol Dial Transplant. 2008 Feb;23(2):673-9 - PubMed
  2. Nephrol Dial Transplant. 2007 Nov;22(11):3285-91 - PubMed
  3. Kidney Int. 2006 May;69(9):1662-8 - PubMed
  4. Nephrology (Carlton). 2011 Sep;16(7):626-32 - PubMed
  5. Nephron. 2015 ;129 Suppl 1:31-56 - PubMed
  6. Nephrol Dial Transplant. 2009 Jul;24(7):2232-40 - PubMed
  7. Health Policy. 1996 Jul;37(1):53-72 - PubMed
  8. Am J Kidney Dis. 2009 Apr;53(4):658-64 - PubMed
  9. BMC Med Res Methodol. 2013 Jul 16;13:92 - PubMed
  10. Spine (Phila Pa 1976). 2006 Mar 15;31(6):639-43 - PubMed
  11. BMC Nephrol. 2012 Jan 19;13:3 - PubMed
  12. Nephrol Dial Transplant. 2011 Apr;26(4):1287-96 - PubMed
  13. Nephrol Dial Transplant. 2003 Nov;18(11):2332-8 - PubMed
  14. Am J Kidney Dis. 2008 Aug;52(2):305-13 - PubMed
  15. Clin J Am Soc Nephrol. 2009 Apr;4(4):778-83 - PubMed
  16. Clin J Am Soc Nephrol. 2009 May;4(5):914-20 - PubMed
  17. Nephrol Dial Transplant. 1998;13 Suppl 6:125-31 - PubMed
  18. Am J Kidney Dis. 2012 May;59(5):689-99 - PubMed
  19. Acta Psychiatr Scand. 1983 Jun;67(6):361-70 - PubMed
  20. Health Policy. 1990 Dec;16(3):199-208 - PubMed
  21. Kidney Int. 2006 Sep;70(5):956-62 - PubMed
  22. Nat Rev Nephrol. 2012 Sep;8(9):515-22 - PubMed
  23. J Am Soc Nephrol. 2001 Dec;12 (12 ):2759-67 - PubMed
  24. Nephron. 2015 ;129 Suppl 1:1-29 - PubMed
  25. Clin J Am Soc Nephrol. 2009 Jun;4(6):1097-101 - PubMed
  26. Clin J Am Soc Nephrol. 2009 Nov;4(11):1779-86 - PubMed
  27. Blood Purif. 2002;20(6):525-30 - PubMed
  28. Hemodial Int. 2010 Jan;14(1):29-38 - PubMed
  29. Nephron. 2015 ;129 Suppl 1:99-129 - PubMed
  30. Clin J Am Soc Nephrol. 2010 Feb;5(2):220-6 - PubMed
  31. Kidney Int. 2011 Nov;80(10):1080-91 - PubMed
  32. Nephrol Dial Transplant. 2010 Feb;25(2):513-9 - PubMed
  33. Kidney Int. 2006 May;69(9):1621-5 - PubMed
  34. Clinics (Sao Paulo). 2011;66(6):991-5 - PubMed
  35. Kidney Int. 2005 Apr;67(4):1500-8 - PubMed
  36. J Am Soc Nephrol. 2012 Apr;23(4):687-95 - PubMed
  37. J Nephrol. 2003 Nov-Dec;16 Suppl 7:S64-9 - PubMed
  38. J Pain Symptom Manage. 2010 Mar;39(3):477-85 - PubMed
  39. Ther Apher Dial. 2013 Aug;17(4):407-11 - PubMed
  40. Hemodial Int. 2011 Apr;15(2):200-10 - PubMed
  41. Nephrol Dial Transplant. 2002 Aug;17(8):1518-21 - PubMed
  42. Clin J Am Soc Nephrol. 2011 Jun;6(6):1326-32 - PubMed

Publication Types